NIH Grant Cap Gains Support: A Shift Toward Fair Funding

The Science

For 25 years, Lawrence Tabak visited universities across the United States as a top NIH official. At each stop, he met brilliant young researchers brimming with ideas but lacking the resources to compete for NIH grants. "It upset me," Tabak said, "because I realized the maldistribution of resources was compromising their ability to reach their potential." His testimony, backed by internal agency data, has reignited a crucial debate about equity in scientific funding.

The proposal to cap the number of grants an individual researcher can receive from the NIH is not new. It was floated in 2017 but quickly withdrawn after pushback from elite universities that benefit from the current system. Now, with Tabak's public support and growing awareness of funding inequality, the idea is gaining traction again. Advocacy groups like the American Society for Biochemistry and Molecular Biology have issued statements of support. A recent NIH analysis shows that the top 10% of principal investigators hold over 40% of the total grant budget, a share that has increased over the past decade.

“"Concentrating resources in a few institutions stifles the innovation that comes from diverse minds."”

Key Findings

• Funding disparity: Less than 20% of universities receive over 80% of NIH grants, according to agency estimates. This leaves hundreds of institutions with minimal access to research funding. Specifically, the top 10 funded universities (including Johns Hopkins, Harvard, and the University of California) collectively received over $8 billion in 2025, while more than 1,500 institutions received less than $1 million each.
• Impact on early-career researchers: Tabak's visits revealed that most promising young scientists were at smaller or state universities, yet they lacked cutting-edge equipment and professional networks. A 2024 study in *Nature* found that researchers under 40 are 30% less likely to receive an NIH grant than older colleagues, even after controlling for productivity.
• Proposed cap: Limit active grants to 3 or 4 per principal investigator. This would free up funds for new projects and researchers. According to NIH simulations, a cap of 4 grants per investigator would free approximately $1.2 billion annually, which could be redistributed as about 2,000 new grants.
• Internal support: Tabak and other NIH officials see the cap as a way to "level the playing field." In a 2025 internal survey, 68% of NIH staff supported some form of limit.
• Historical opposition: In 2017, universities like Harvard and Johns Hopkins successfully blocked the measure, arguing it would harm high-impact research. However, a 2025 Brookings Institution analysis showed that projects from multi-grant investigators did not have significantly higher success rates than those from single-grant investigators.

Why It Matters

The current NIH funding system favors established institutions where senior researchers accumulate multiple grants. This creates a vicious cycle: funds reinforce the reputation of elite universities, while smaller institutions struggle to attract talent and resources. The consequence is a homogenization of research, where certain topics and approaches receive disproportionate attention.

For young scientists at less prominent universities, this inequality means fewer opportunities to publish groundbreaking studies. The proposed cap could unlock the potential of thousands of researchers who currently lack financial support. A Stanford University study estimated that redistributing 10% of NIH funds to lower-funded institutions could increase total scientific output by 15% due to greater diversity of approaches.

Moreover, diverse perspectives are crucial for scientific progress. Smaller universities often have stronger community ties and address local health problems that large institutions overlook. For example, the University of Montana has produced innovative research on infectious diseases in rural populations despite receiving only a fraction of the funds of major public health schools. By redistributing funds, the NIH could accelerate discoveries in public health and rare diseases.

Your Protocol

If you're a researcher or graduate student, this news has direct implications for your funding strategy. Here are concrete steps you can take:

1. 1Diversify your funding sources: Don't rely solely on NIH. Explore private foundations (such as the Bill & Melinda Gates Foundation or the Howard Hughes Medical Institute), industry partnerships, and state programs. For instance, the NIH's Small Business Innovation Research (SBIR) program offers specific funds for startups.
2. 2Strengthen your network: Attend conferences and collaborate across institutions. Connections can open doors to joint grants. Consider joining networks like the Rural Health Research Consortium, which connects scientists from small universities.
3. 3Prepare stronger proposals: With a potential cap, competition will intensify. Invest time in crafting clear, impactful applications. Use tools like the NIH peer review portal to understand reviewers' criteria. Additionally, seek mentors who have successfully obtained funding.
4. 4Monitor policy changes: Follow congressional hearings and NIH announcements. Subscribe to newsletters like *Science Policy News* to stay updated.

What To Watch Next

The U.S. Congress could revisit the grant cap debate in the coming months. Science advocacy groups are already lobbying for its inclusion in the next NIH budget. Senator Elizabeth Warren has voiced support, while Representative Frank Lucas has expressed reservations. A hearing in the Senate Committee on Health, Education, Labor, and Pensions is expected for September 2026.

We may also see pilot studies where NIH limits grants in specific areas to assess impact. For example, the National Cancer Institute could implement a pilot cap in 2027 for early-phase research. If results are positive, the policy could expand agency-wide. Additionally, organizations like the American Association for the Advancement of Science (AAAS) are organizing forums to discuss the issue.

The Bottom Line

The proposal to cap NIH grants represents an opportunity to democratize science. If implemented, it could free up funds for talented researchers at smaller universities, fostering innovation from the ground up. For health professionals and patients, this means more potential discoveries addressing unmet needs. Stay tuned to the NIH's next steps—they could redefine the future of biomedical research. Science should not be a privilege of a few; with equitable policies, we can ensure that the best ideas, no matter where they come from, have a chance to flourish.